ELV - Elevance Health, Inc.
NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 110.28B |
| Enterprise Value | 125.60B |
| Trailing P/E | 18.04 |
| Forward P/E | 14.16 |
| PEG Ratio (5 yr expected) | 1.13 |
| Price/Sales (ttm) | 0.70 |
| Price/Book (mrq) | 2.95 |
| Enterprise Value/Revenue | 0.78 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.85 |
| 52-Week Change 3 | -5.84% |
| S&P500 52-Week Change 3 | 2.74% |
| 52 Week High 3 | 549.52 |
| 52 Week Low 3 | 438.56 |
| 50-Day Moving Average 3 | 463.68 |
| 200-Day Moving Average 3 | 484.21 |
Share Statistics
| Avg Vol (3 month) 3 | 1.13M |
| Avg Vol (10 day) 3 | 1.22M |
| Shares Outstanding 5 | 237.06M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 236.63M |
| % Held by Insiders 1 | 0.21% |
| % Held by Institutions 1 | 92.75% |
| Shares Short (May 14, 2023) 4 | 1.84M |
| Short Ratio (May 14, 2023) 4 | 1.71 |
| Short % of Float (May 14, 2023) 4 | 0.78% |
| Short % of Shares Outstanding (May 14, 2023) 4 | 0.78% |
| Shares Short (prior month Apr 13, 2023) 4 | 1.64M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 5.92 |
| Forward Annual Dividend Yield 4 | 1.27% |
| Trailing Annual Dividend Rate 3 | 5.32 |
| Trailing Annual Dividend Yield 3 | 1.19% |
| 5 Year Average Dividend Yield 4 | 1.11 |
| Payout Ratio 4 | 20.63% |
| Dividend Date 3 | Jun 22, 2023 |
| Ex-Dividend Date 4 | Jun 07, 2023 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | May 31, 2005 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2022 |
| Most Recent Quarter (mrq) | Mar 30, 2023 |
Profitability
| Profit Margin | 3.87% |
| Operating Margin (ttm) | 5.62% |
Management Effectiveness
| Return on Assets (ttm) | 5.39% |
| Return on Equity (ttm) | 16.99% |
Income Statement
| Revenue (ttm) | 160.68B |
| Revenue Per Share (ttm) | 672.21 |
| Quarterly Revenue Growth (yoy) | 10.70% |
| Gross Profit (ttm) | 40.11B |
| EBITDA | 10.21B |
| Net Income Avi to Common (ttm) | 6.22B |
| Diluted EPS (ttm) | 25.78 |
| Quarterly Earnings Growth (yoy) | 11.20% |
Balance Sheet
| Total Cash (mrq) | 38.17B |
| Total Cash Per Share (mrq) | 161.02 |
| Total Debt (mrq) | 26.37B |
| Total Debt/Equity (mrq) | 70.40 |
| Current Ratio (mrq) | 1.43 |
| Book Value Per Share (mrq) | 157.54 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 12.33B |
| Levered Free Cash Flow (ttm) | 9.2B |
© 2023 Yahoo. All rights reserved.